NuVasive receives Japanese regulatory approval for Reline posterior fixation technology


NuVasive has received regulatory Shonin approval for its Reline posterior fixation technology in Japan. According to a company release, this approval will prepare the market for the launch of the company’s Integrated Global Alignment (iGA) platform.

Jason M Hannon, executive vice president, International, says, “We are very pleased to receive regulatory approval of Reline in Japan as it moves us toward launching…iGA technology in our largest and fastest growing international market.”

“With the pending launch of iGA in Japan, we expect to drive robust adoption of this technology to address proper spinal alignment and drive improved long-term patient outcomes,” Hannon concludes.